EPO and anemia (phenotype): Several examples illustrate this purpose, such as increasing dialysis dose delivery by adjusting blood flow and effective treatment time, promoting the increased use of native arteriovenous fistula, reducing erythropoietin use to correct anemia, and improving fluid volume management when combined with bioimpedance devices.